Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
5
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
san diego blog main
5
×
san diego top stories
clinical trials
fda
akcea therapeutics
drugs
inotersen
onpattro
patisiran
san francisco blog main
san francisco top stories
tafamidis
abbvie
alnylam pharmaceuticals
astrazeneca
avexis
biotech
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
eli lilly
genentech
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
johnson & johnson
microbiome
national
What
fda
5
×
drug
alnylam
approved
bio
disease
medicine
news
rnai
roundup
afternoon
ago
akcea
alnylam’s
amyloidosis
approves
attr
august
available
battle
biotech
busy
cells
companies
days
debilitating
decisions
devices
digital
drugs
ema
employ
epidemic
europe
fatty
follows
frenzied
gene
genetic
gets
Language
unset
Current search:
pfizer
×
" san diego blog main "
×
fda
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug